Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 1.000
-0.030 (-2.91%)
Jun 18, 2026, 4:53 PM CET
STO:MAGLE Revenue
Magle Chemoswed Holding AB had revenue of 68.62M SEK in the quarter ending March 31, 2026, a decrease of -17.24%. This brings the company's revenue in the last twelve months to 273.25M, down -4.08% year-over-year. In the year 2025, Magle Chemoswed Holding AB had annual revenue of 287.55M with 19.53% growth.
Revenue (ttm)
273.25M
Revenue Growth
-4.08%
P/S Ratio
0.10
Revenue / Employee
1.82M
Employees
150
Market Cap
28.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 287.55M | 46.98M | 19.53% |
| Dec 31, 2024 | 240.57M | 69.07M | 40.27% |
| Dec 31, 2023 | 171.50M | 23.51M | 15.89% |
| Dec 31, 2022 | 147.98M | 15.84M | 11.98% |
| Dec 31, 2021 | 132.15M | -10.19M | -7.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alzinova AB | 25.66M |
| Fluicell AB | 20.15M |
| Spago Nanomedical AB | 4.38M |
| Aptahem AB | 2.52M |
| Biosergen AB | 2.09M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 1.13M |
| NanoEcho AB | 487.00K |
Magle Chemoswed Holding AB News
- 21 days ago - Magle Chemoswed Holding AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Magle Chemoswed Holding AB Quarterly report: Q4 2025 - Filings
- 7 months ago - Magle Chemoswed Holding AB Quarterly report: Q3 2025 - Filings
- 11 months ago - Magle Chemoswed Holding AB Quarterly report: Q2 2025 - Filings